William P. Vostrejs
UPMC Hillman Cancer Center(US)University of Pennsylvania(US)
Publications by Year
Research Areas
Pancreatic and Hepatic Oncology Research, Cancer Research and Treatments, Cancer Immunotherapy and Biomarkers, Biochemical and Molecular Research, Protein Kinase Regulation and GTPase Signaling
Most-Cited Works
- → Efficacy of a Small-Molecule Inhibitor of KrasG12D in Immunocompetent Models of Pancreatic Cancer(2022)339 cited
- → Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer(2024)157 cited
- → T-cell Dependency of Tumor Regressions and Complete Responses with RAS(ON) Multi-selective Inhibition in Preclinical Models of Pancreatic Ductal Adenocarcinoma(2025)26 cited
- → The YBX3 RNA-binding protein posttranscriptionally controls SLC1A5 mRNA in proliferating and differentiating skeletal muscle cells(2023)10 cited
- → N-glycosylation by Mgat5 imposes a targetable constraint on immune-mediated tumor clearance(2024)9 cited
- → Evidence for in vitro extensive proliferation of adult hepatocytes and biliary epithelial cells(2023)5 cited
- → Author Correction: Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer(2024)4 cited
- → Supplementary Figure S7 from T-cell Dependency of Tumor Regressions and Complete Responses with RAS(ON) Multi-selective Inhibition in Preclinical Models of Pancreatic Ductal Adenocarcinoma(2025)
- → Supplementary Figure S12 from T-cell Dependency of Tumor Regressions and Complete Responses with RAS(ON) Multi-selective Inhibition in Preclinical Models of Pancreatic Ductal Adenocarcinoma(2025)
- → Supplementary Table from Efficacy of a Small-Molecule Inhibitor of Kras<sup>G12D</sup> in Immunocompetent Models of Pancreatic Cancer(2023)